Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

4.590 +0.080 (+1.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,594,072
Open 4.560
Bid (Size) 4.560 (7)
Ask (Size) 4.640 (1)
Prev. Close 4.510
Today's Range 4.430 - 4.840
52wk Range 2.865 - 9.305
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks are being observed in Tuesday's session.
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Performance

YTD
-23.6%
-23.6%
1 Month
-20.5%
-20.5%
3 Month
-24.8%
-24.8%
6 Month
-15.9%
-15.9%
1 Year
-31.9%
-31.9%

More News

Read More
Why Verve Therapeutics Is Skyrocketing Today
Via The Motley Fool
The market is filled with gapping stocks in Tuesday's session.
Via Chartmill
Analyst Scoreboard: 4 Ratings For Verve Therapeutics
Via Benzinga
Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Monday
Via Benzinga
Assessing Verve Therapeutics: Insights From 4 Financial Analysts
Via Benzinga
Gapping stocks in Monday's session
Via Chartmill
Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
From Verve Therapeutics
Via GlobeNewswire
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
From Climb Bio, Inc.
Via GlobeNewswire
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Verve Therapeutics
Via GlobeNewswire
Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?
Via Investor's Business Daily
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Verve Therapeutics
Via GlobeNewswire
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
From Verve Therapeutics
Via GlobeNewswire

Frequently Asked Questions

Is Verve Therapeutics, Inc. - Common Stock publicly traded?
Yes, Verve Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Verve Therapeutics, Inc. - Common Stock trade on?
Verve Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Verve Therapeutics, Inc. - Common Stock?
The ticker symbol for Verve Therapeutics, Inc. - Common Stock is VERV on the Nasdaq Stock Market
What is the current price of Verve Therapeutics, Inc. - Common Stock?
The current price of Verve Therapeutics, Inc. - Common Stock is 4.590
When was Verve Therapeutics, Inc. - Common Stock last traded?
The last trade of Verve Therapeutics, Inc. - Common Stock was at 04/17/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.